Towards a vaccine candidate against Shigella dysenteriae 1: Expression of the Shiga toxin B-subunit in an attenuated Shigella flexneri aroD carrier strain

Microbial Pathogenesis

Volumn 21, Issue 4, 1996, Pages 277-288

  Tzschaschel, Barbara D ^a   Klee, Silke R ^a   De Lorenzo, Victor ^b   Timmis, Kenneth N ^a   Guzmán, Carlos A ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

Shiga toxin; Shigella dysenteriae 1; shigellosis; vaccine

Indexed keywords

POLYCLONAL ANTIBODY; SHIGA TOXIN; SHIGELLA VACCINE;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLOSIS; TRANSPOSON; VACCINATION;

ESCHERICHIA COLI; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI;

EID: 0030272907     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1996.0061     Document Type: Article

References (42)

1. 1. Katz SL. The prospects for immunizing against Shigella spp., In: New vaccine development Vol. 2. Diseases of importance in developing countries. Washington, DC: National Academy Press, 1986: 329-37.
2. 2. Lindberg AA, Cam PD, Chan N, Phu LK, Trach DD, Lindberg G. Shigellosis in Vietnam: seroepidemiological studies with use of lipopolysaccharide antigens in enzyme immunoassays. Rev Infect Dis 1991; 13(Suppl. 4): 231-7.
3. 3. Kapperud G, Rorvik LM, Hasseltvedt V, Hoiby E, Iversen BG, Staveland K, Johnsen G, Leitao J, Herikstad H, Andersson Y, Langeland G, Gondrosen B, Lassen J. Outbreak of Shigella sonnei infection traced to imported iceberg lettuce. J Clin Microbiol 1995; 33: 609-14.
4. 4. Black RE, Levine M, Clements ML, Losonsky G, Herrington D, Bergman S, Formal SB. Prevention of Shigellosis by a Salmonela typhi-Shigella sonnei bivalent vaccine. J Infect Dis 1987; 155: 1260-5.
5. 5. Chu C-Y, Liu B, Watson D, Szu SC, Bryla K, Shiloach J, Schneerson R, Robbins JB. Preparation, characterization and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid. Infect Immun 1992; 40: 245-56.
6. 6. Li A, Cam PD, Islam D, Minh NB, Huan PT, Rong ZC, Karlsson K, Lindberg G, Lindberg AA. Immune responses in Vietnamese children after a single dose of the auxotrophic, live Shigella flexneri Y vaccine strain SFL124. J Infection 1994; 28: 11-23.
7. 7. Lindberg AA, Brown JE, Ströberg N, Westling-Ryd M, Schultz JE, Karlson KA. Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J Biol Chem 1987; 262: 1779-85.
8. 8. Endo Y, Tsurugi K, Yutsudo T, Takeda T, Ogasawara T, Igarashi K. Site of action of a Vero toxin(VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem 1988; 171: 45-50.
9. - mutant of Shigella dysenteriae 1. Infect Immun 1988; 56: 3099-109.
10. 10. DuPont HL, Levine MM, Hornick RB, Formal SB. Inoculum size in shigellosis and implications for expected mode of transmission. J Infect Dis 1989; 159: 1126-8.
11. 11. Donohue-Rolfe A, Keusch GT. Shigella dysenteriae 1 cytotoxin: periplasmic protein releasable by polymyxin B and osmotic shock. Infect Immun 1983; 39: 270-4.
12. 12. McEwen J, Leitner M, Harrari I,Arnon R. Expression of Shiga toxin epitopes in E. coli, immunological characterization. Immunol Lett 1989; 21: 157-63.
13. 13. Kärnell A, Stocker BAD. An auxotrophic live oral Shigella flexneri vaccine: development and testing. Rev Infect Dis 1991; 13(Suppl 4): 357-61.
14. 14. Kärnell A, Stocker BAD, Katakura S, Reinholt FP, Lindberg AA. Live oral auxotrophic Shigella flexneri SFL124 vaccine with a deleted aroD gene: characterisation and monkey protection studies. Vaccine 1991; 10:389-94.
15. 15. Klee S. Konstruction and Characterisierung bi-und monovalenter Impfstoffkandidaten gegen Bakterienruhr auf der Basis attenuierter Trägerstämme von Shigella flexneri, die stabil das O-Antigen von S. dysenteriae 1 exprimieren. PhD thesis, University of Braunschweig 1996.
16. 16. Su G-F, Brahmbhatt HN, de Lorenzo V, Wehland J, Timmis KN. Extracellular export of Shiga toxin-subunit/haemolysin A (C-terminus) fusion protein expressed in Salmonella typhimurium aroA-mutant and stimulation of B-subunit specific antibody responses in mice. Microb Pathogen 1992; 13: 465-76.
17. 17. Holland IB, Wang R, Seror SJ, Blight M. Haemolsyin secretion and other protein translocation mechanisms in gram-negative bacteria, In: Baumberg S, Hinster I, Rhodes M, eds. Microbial Products, New Approaches. Cambridge: Cambridge University Press, 1990: 219-54.
18. 18. Koronakis V, Stanley P, Koronakis E, Hughes C. The HlyB/HlyD-dependent secretion of toxins by Gram-negative bacteria. FEMS Microbiol Immunol 1992; 105: 45-54.
19. 19. Herrero M, de Lorenzo V, Timmis KN. Transposon vectors containing non-antibiotic resistance selection markers for cloning and stable chromosomal insertion of foreign genes in Gram-negative bacteria. J Bacteriol 1990; 172: 6557-67.
20. r and the IncII Plasmid pHH1508a. J Bacteriol 1989; 171: 2160-5.
21. 21. World Health Organization. Development of vaccines against shigellosis: memorandum from a WHO meeting. Bull WHO 1987; 65: 17-25.
22. 22. Li A, Kärnell A, Huan PT. Cam PD, Minh NB, Tram LN, Quy NP, Trach DD, Karlsson K. Lindberg G, Lindberg AA. Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in adult Vietnamese volunteers. Vaccine 1993; 11: 180-9.
23. 23. Li A, Pál T, Forsun U, Lindberg, AA. Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in volunteers. Vaccine 1992; 10: 395-404.
24. 24. Manoil C, Beckwith J. TnphoA: a transposon probe for protein export signals. Proc Natl Acad Sci USA 1985; 82: 8129-33.
25. 25. Simon R, Priefer U, Pühler A. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram negative bacteria. Bio/Technology 1983; 1:784-91.
26. 26. Yanisch-Perron C, Vieira J, Messing J. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 1985; 33: 103-19.
27. 27. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, 2nd edition. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1982.
28. 28. Miller VL, Mekalanos JJ. A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol 1988; 170: 2575-83.
29. 29. Takeshita S, Sato M, Toba M, Masahashi W, Hashimoto-Gotoh T. High-copy number and low-copy number plasmid vectors for lacZα-complementation and chloramphenicol-or kanamycin-resistant selection. Gene 1987; 61: 63-74.
30. 30. Felmlee T, Pellett S, Welsh RA. Nucleotide sequence of an Escherichia coli chromosomal hemolysin. J Bacteriol 1985; 163: 94-105.
31. 31. Gray L, Mackman N, Nicaud J-M, Holland IB. The carboxy-terminal region of haemolysin 2001 is required for secretion of the toxin from Escherichia coli. Mol Gen Genet 1986; 205: 127-33.
32. 32. Hanahan D. Studies in transformation of Escherichia coli with plasmids. J Mol Biol 1983; 166: 577-80.
33. 33. O'Callaghan D, Charbit A. High efficiency transformation of Salmonella typhimurium and Salmonella typhi by electroporation. Mol Gen Genet 1990; 223: 156-8.
34. 34. Laemmli UK. Cleavage of structural proteins during assembly of the heads of bacteriophage T4. Nature 1970; 227: 680-5.
35. 35. Towbin H, Staehlin H, Gordon G. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4.
36. 36. Niebuhr K. Biochemische und immunologische Charakterisierung der rekombinanten B-Untereinheit des Shiga Toxins. Diploma Thesis 1991; University of Braunschweig.
37. 37. Hitchcock PJ, Brown TM. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver stained polyacrylamide gels. J Bacteriol 1983; 154: 269-77.
38. 38. Fält IC, Sweda EKH, Klee S, Singh M, Floderus E, Timmis KN, Lindberg AA. Expression of Shigella dysenteriae serotype 1 O-antigenic polysaccharide by Shigella flexneri aroD vaccine candidates and different S. flexneri serotypes. J Bacteriol 1995; 177: 5310-5.
39. 39. Kado Cl, Liu ST. Rapid procedure for detection and isolation of large and small plasmids. J Clin Microbiol 1981; 30: 2801-6.
40. 40. Monner DA. An assay for growth of mouse bone marrow cells in microtiter liquid culture using the terazolium salt MTT, and its application to studies of myelopoiesis. Immunol Lett 1988; 19: 261-8.
41. 41. Nicaud JM, Mackman M, Gray L, Holland IB. The C-terminal, 23 kDa peptide of E. coli haemolysin 2001 contains all the information necessary for its secretion by the haemolysin (Hly) export machinery. FEBS Letters 1986; 204: 331-5.
42. 42. Mackman N, Nicaud J-M, Gray L, Holland IB. Genetical and functional organisation of the Escherichia coli haemolysin determinants 2001. Mol Gen Genet 1985; 201: 282-8.